Defunct Company
Total Trials
11
As Lead Sponsor
2
As Collaborator
9
Total Enrollment
4,063
NCT00432536
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Phase: N/A
Role: Collaborator
Start: Oct 31, 2002
Completion: Feb 29, 2012
NCT00291824
Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2004
Completion: Feb 28, 2006
NCT00393393
Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee
Phase: Phase 4
Start: Jan 31, 2006
Completion: Jan 31, 2006
NCT00922441
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
Phase: Phase 2
Start: Dec 31, 2008
Completion: Aug 31, 2009
NCT01365572
New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )
Start: Jan 31, 2010
Completion: Mar 31, 2012
NCT02145858
Prevention of Retained-Blood Outcomes With Active Clearance Technology
Start: Jun 30, 2014
Completion: Nov 30, 2016
NCT02843022
Effectiveness of a Web-based Nursing Intervention in the Reduction of Postpartum Depression and Parenting Stress.
Start: Nov 30, 2015
Completion: Feb 28, 2018
NCT03813134
Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock
Start: Oct 11, 2019
Completion: Feb 1, 2024
NCT04552275
The HALT Biomarker Study
Start: Jun 22, 2020
Completion: Jun 22, 2035
NCT05460780
First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer
Start: Jul 1, 2022
Completion: Dec 31, 2028
NCT07000539
Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery
Start: May 6, 2025
Completion: Feb 28, 2026